CN106290898A - 一种金‑上转换纳米粒子三聚体的制备方法及其应用 - Google Patents
一种金‑上转换纳米粒子三聚体的制备方法及其应用 Download PDFInfo
- Publication number
- CN106290898A CN106290898A CN201610613233.8A CN201610613233A CN106290898A CN 106290898 A CN106290898 A CN 106290898A CN 201610613233 A CN201610613233 A CN 201610613233A CN 106290898 A CN106290898 A CN 106290898A
- Authority
- CN
- China
- Prior art keywords
- gold
- conversion nanoparticles
- trimer
- afp
- mucin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- Microbiology (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Composite Materials (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Manufacturing & Machinery (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
一种金‑上转换纳米粒子三聚体的制备方法及其应用,属于分析化学技术领域。本发明主要包括20nm粒径的金纳米粒子的合成、金纳米粒子上Mucin‑1适配体的修饰、上转换纳米粒子上AFP适配体的修饰、金纳米粒子上AFP和Mucin‑1适配体部分互补序列的修饰、金‑上转换纳米粒子三聚体的组装、荧光和拉曼检测;在外加AFP后,荧光会增强;而在外加Mucin‑1后,拉曼信号会减弱,从而建立荧光信号与AFP浓度、拉曼信号与Mucin‑1浓度的标准曲线。本发明提供了一种用金‑上转换纳米粒子三聚体对癌症标志物的多重超灵敏检测方法,与传统检测方法相比成本低,灵敏度高,方便快捷,具有很好的实际应用前景。
Description
技术领域
本发明涉及一种金-上转换纳米粒子三聚体的制备方法及其应用,属于分析化学技术领域。
背景技术
甲胎蛋白(α-fetoprotein,AFP),是一种致癌糖蛋白,是诊断原发性肝癌的特异性肿瘤标志物,具有确立诊断、早期诊断、鉴别诊断的作用。大量的临床发现,70%-95% 的原发性肝癌患者的AFP 升高。粘蛋白-1(Mucin-1)发生在许多腺癌,包括胰腺癌、肺癌、乳腺癌、卵巢癌、结肠癌和其它组织。粘蛋白也过度表达在肺疾病,如哮喘、支气管炎、慢性阻塞性肺病或囊性纤维化。Mucin-1正诊断标记为恶性肿瘤和其他疾病过程中,通常会过度或错误表达。
传统检测癌症标志物的方法有:酶联免疫法、电化学和基于仪器的液质联用、高效液相色谱等。酶联免疫法检测肿瘤标志物时,因蛋白质容易热变性,所以很难检测蛋白类肿瘤标志物,另外酶联免疫法的灵敏度较低,而且耗力耗时;电化学对样品的基质要求较高,很难实施;而用仪器检测时成本很高,并且对操作人员的操作技能有很高的要求。
所以,本发明提出了一种新型的、简便的、灵敏的检测方法,把纳米材料作为一种新型探针,进行AFP和Mucin-1的超灵敏检测。
通过 DNA 杂交将20nm粒径的金纳米粒子和20nm粒径的上转换纳米粒子组装成三聚体结构。目标物AFP和其适配体部分互补序列修饰的上转换纳米粒子竞争结合,荧光信号增强;而目标物Mucin-1和其适配体部分互补序列修饰的金纳米粒子竞争结合,拉曼信号减弱。将荧光信号与目标物AFP的浓度建立标准曲线,拉曼信号与目标物Mucin-1的浓度建立标准曲线,以此来定量检测癌症标志物甲胎蛋白及粘蛋白-1。
发明内容
本发明的目的是提供一种金-上转换纳米粒子三聚体的制备方法及其应用,其提供的新型的、简便的、灵敏的检测方法,把纳米材料作为一种新型探针,进行AFP和Mucin-1的超灵敏检测。
本发明的技术方案,一种金-上转换纳米粒子三聚体的制备方法,具体包括金纳米粒子的合成,上转换纳米粒子的提供,金-上转换纳米粒子三聚体的组装及结构表征,荧光、拉曼信号测试,用金-上转换纳米粒子三聚体检测AFP和Mucin-1。具体步骤如下:
(1)金纳米粒子的合成:进行20nm 粒径金纳米粒子的合成;48.75mL超纯水在搅拌下加入1.25mL 4g/L的氯金酸,使其沸腾,沸腾状态保持2-3min,加入1.2mL 10mg/mL的柠檬酸钠水溶液,观察颜色变化,待颜色不变后冷却至室温,放入冰箱中待用:
(2)上转换纳米粒子的提供:由北京万德高科技发展有限公司购买;
(3)金-上转换纳米粒子三聚体的组装:取两管50mL步骤(1)制备的已浓缩好的 10nM20nm粒径金纳米粒子,分别与巯基修饰的Mucin-1的适配体及互补序列进行偶联,金纳米粒子︰巯基修饰的Mucin-1的适配体/互补序列的摩尔比为1︰3;再将50mL上转换纳米粒子与巯基修饰的AFP的适配体偶联,其中上转换纳米粒子︰巯基修饰的AFP摩尔比为1︰5;三管试剂均在室温下过夜反应,13000r/min 离心15min,弃上清,然后用50mL的TBE缓冲液分散沉淀,分别得到Au-Mucin-1适配体、Au-互补序列及UCNP- AFP适配体,待用;
将50mL Au-Mucin-1适配体、50mL Au-互补序列和50mL UCNP- AFP适配体杂交反应12h,得到组装产物金-上转换纳米粒子三聚体Au-Au-UCNP;离心15min,弃上清,后用100mL的超纯水分散,进行TEM、荧光和拉曼表征。
Mucin-1适配体:5’-GCAGTTGATC CTTTGGATAC CCTGG-SH-3’;
互补序列:5’-GATCAACTGC ACAGCACCAC AGACC-SH-3’;
AFP适配体:5’-SH-GGCAGGAAGA CAAACAGGAC CGGGTTGTGT GGGGTTTTAA GAGCGTCGCCTGTGTGTGGT CTGTGGTGCT GT-3’。
金-上转换纳米粒子三聚体的应用,用于癌症标志物的多重超灵敏检测,具体采用金-上转换纳米粒子三聚体检测甲胎蛋白AFP和粘蛋白-1Mucin-1。
(4)AFP的检测:取100mL的金-上转换纳米粒子三聚体Au-Au-UCNP,加入1mL不同浓度的甲胎蛋白(AFP),使其终浓度在0-100aM(具体为 0、1、2、5、10、20、50、100 aM),反应10min,进行荧光测试,绘制标准曲线。
(5) Mucin-1的检测:取100mL的金-上转换纳米粒子三聚体Au-Au-UCNP,加入1mL不同浓度的粘蛋白-1(Mucin-1),使其终浓度在0-10fM(具体为 0、0.01、0.05、0.1、0.5、1、5、10 fM),反应 10min,进行拉曼测试,绘制标准曲线。
(6)样品测试:从无锡市第二人民医院获取三名病人的血清样品,稀释后取1mL,加入100mL Au-Au-UCNP组装体,进行荧光和拉曼测试,根据标准曲线得出样品所含AFP及Mucin-1的浓度,并与标准浓度进行比较。
本发明的有益效果:本发明基于荧光和拉曼作为检测信号,可以分别检测两种癌症标志物甲胎蛋白AFP及粘蛋白-1Mucin-1。与传统的检测手段相比,具有灵敏度高、检测限低、方便、快捷的优点,有非常好的应用前景。
附图说明
图1金-上转换纳米粒子三聚体Au-Au-UCNP组装结构的 TEM 图。
图 2 不同浓度AFP下金-上转换纳米粒子三聚体的荧光信号。
图 3 基于金-上转换纳米粒子三聚体组装结构进行AFP检测标准曲线。
图 4 不同浓度Mucin-1下金-上转换纳米粒子三聚体的拉曼信号。
图 5 基于金-上转换纳米粒子三聚体组装结构进行Mucin-1检测标准曲线。
具体实施方式
以下实施例中的上转换纳米粒子购自北京万德高科技发展有限公司。
实施例 1 基于金-上转换纳米粒子三聚体的癌症标志物的多重超灵敏检测方法。
(1)金纳米粒子的合成:将48.75mL超纯水在搅拌下加入1.25mL 4g/L的氯金酸,使其沸腾,沸腾状态保持2-3min,加入1.2mL 10mg/mL的柠檬酸钠水溶液,观察颜色变化,待颜色不变后冷却至室温,放入冰箱中待用。
(2)上转换纳米粒子的提供:由北京万德高科技发展有限公司购买。
(3)金-上转换纳米粒子三聚体的组装:取两管50mL已浓缩好的20nm粒径金纳米粒子,分别与巯基修饰的Mucin-1的适配体及互补序列进行偶联,偶联摩尔比为1︰3;再将50mL上转换纳米粒子与巯基修饰的AFP的适配体偶联,偶联摩尔比为1︰5,三管在室温下过夜反应,13000r/min 离心15min,弃上清,然后用50 mL的TBE缓冲液分散沉淀,待用;将50 mLAu-Mucin-1适配体、50 mL Au-互补序列、50 mL UCNP- AFP适配体杂交反应12h,组装产物为金-上转换纳米粒子三聚体Au-Au-UCNP,离心15min,弃上清,后用100mL的超纯水分散,进行TEM、荧光和拉曼表征。
(4)AFP的检测:取100mL的金-上转换纳米粒子三聚体,加入1 mL 不同浓度的AFP溶液,使其终浓度范围分别为 0、1、2、5、10、20、50、100 aM,反应 10min,进行荧光测试。最低检测限达0.059aM。
(4) Mucin-1的检测:取100mL的金-上转换纳米粒子三聚体,加入1 mL不同浓度的Mucin-1溶液,使其终浓度范围分别为0、0.01、0.05、0.1、0.5、1、5、10 fM,反应 10min,进行拉曼测试。最低检测限达4.1aM。
Claims (5)
1.一种金-上转换纳米粒子三聚体的制备方法,其特征在于包括金纳米粒子的合成,上转换纳米粒子的提供,金-上转换纳米粒子三聚体的组装及结构表征,具体步骤如下:
(1)金纳米粒子的合成:进行20nm 粒径金纳米粒子的合成;48.75mL超纯水在搅拌下加入1.25mL 4g/L的氯金酸,使其沸腾,沸腾状态保持2-3min,加入1.2mL 10mg/mL的柠檬酸钠水溶液,观察颜色变化,待颜色不变后冷却至室温,放入冰箱中待用;
(2)上转换纳米粒子的提供:由北京万德高科技发展有限公司购买;
(3)金-上转换纳米粒子三聚体的组装:取两管50mL步骤(1)制备的已浓缩好的 10nM20nm粒径金纳米粒子,分别与巯基修饰的Mucin-1的适配体及互补序列进行偶联,金纳米粒子︰巯基修饰的Mucin-1的适配体/互补序列的摩尔比为1︰3;再将50mL上转换纳米粒子与巯基修饰的AFP的适配体偶联,其中上转换纳米粒子︰巯基修饰的AFP摩尔比为1︰5;三管试剂均在室温下过夜反应,13000r/min 离心15min,弃上清,然后用50mL的TBE缓冲液分散沉淀,分别得到Au-Mucin-1适配体、Au-互补序列及UCNP- AFP适配体,待用;
将50mL Au-Mucin-1适配体、50mL Au-互补序列和50mL UCNP- AFP适配体杂交反应12h,得到组装产物金-上转换纳米粒子三聚体Au-Au-UCNP;离心15min,弃上清,后用100mL的超纯水分散,进行TEM、荧光和拉曼表征。
2.根据权利要求1所述金-上转换纳米粒子三聚体的制备方法,其特征在于:
Mucin-1适配体:5’-GCAGTTGATC CTTTGGATAC CCTGG-SH-3’;
互补序列:5’-GATCAACTGC ACAGCACCAC AGACC-SH-3’ ;
AFP适配体:5’-SH-GGCAGGAAGA CAAACAGGAC CGGGTTGTGT GGGGTTTTAA GAGCGTCGCCTGTGTGTGGT CTGTGGTGCT GT-3’。
3.用权利要求1方法制备的金-上转换纳米粒子三聚体的应用,其特征在于:用于癌症标志物的多重超灵敏检测,具体采用金-上转换纳米粒子三聚体检测甲胎蛋白AFP和粘蛋白-1Mucin-1。
4.根据权利要求3所述金-上转换纳米粒子三聚体的应用,其特征在于具体步骤如下:
(1)AFP的检测:取100mL的金-上转换纳米粒子三聚体Au-Au-UCNP,加入1mL不同浓度的甲胎蛋白AFP,使其终浓度在0-100aM,反应10min,进行荧光测试,绘制标准曲线;
(2)Mucin-1的检测:取100mL的金-上转换纳米粒子三聚体Au-Au-UCNP,加入1mL不同浓度的粘蛋白-1Mucin-1,使其终浓度在0-10fM,反应 10min,进行拉曼测试,绘制标准曲线;
(3)样品测试:以血清样品,稀释后取1mL,加入100mLAu-Au-UCNP组装体,进行荧光和拉曼测试,根据标准曲线得出样品所含AFP及Mucin-1的浓度,并与标准浓度进行比较。
5.根据权利要求4所述金-上转换纳米粒子三聚体的应用,其特征在于所述不同浓度的甲胎蛋白AFP具体为0、1、2、5、10、20、50、100aM;不同浓度的粘蛋白-1Mucin-1具体为0、0.01、0.05、0.1、0.5、1、5、10fM。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610613233.8A CN106290898B (zh) | 2016-07-29 | 2016-07-29 | 一种金‑上转换纳米粒子三聚体的制备方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610613233.8A CN106290898B (zh) | 2016-07-29 | 2016-07-29 | 一种金‑上转换纳米粒子三聚体的制备方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106290898A true CN106290898A (zh) | 2017-01-04 |
CN106290898B CN106290898B (zh) | 2017-11-28 |
Family
ID=57663240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610613233.8A Active CN106290898B (zh) | 2016-07-29 | 2016-07-29 | 一种金‑上转换纳米粒子三聚体的制备方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106290898B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109097356A (zh) * | 2018-09-07 | 2018-12-28 | 江南大学 | 一种基于金壳-上转换纳米颗粒手性五聚组装体的制备方法 |
CN109283333A (zh) * | 2018-09-21 | 2019-01-29 | 江南大学 | 一种基于金壳-上转换手性二聚体对大肠杆菌耐药性定量分析的方法 |
CN111624186A (zh) * | 2020-06-24 | 2020-09-04 | 江南大学 | 一种基于荧光和拉曼双信号增强的肠毒素光谱分析方法 |
CN111999504A (zh) * | 2020-08-10 | 2020-11-27 | 江南大学 | 一种粘蛋白1及其唾液酸糖基的双重荧光成像方法及应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005098441A2 (en) * | 2004-03-30 | 2005-10-20 | Intel Corporation | Method to detect molecular binding by surface-enhanced raman spectroscopy |
CN101484002A (zh) * | 2006-05-03 | 2009-07-15 | 加利福尼亚大学董事会 | 使用单个纳米新月形表面增强拉曼散射探针检测蛋白酶和蛋白酶活性 |
US20130330839A1 (en) * | 2010-11-24 | 2013-12-12 | Snu R&Db Foundation | Single nanoparticle having a nanogap between a core material and a shell material, and preparation method thereof |
CN104263837A (zh) * | 2014-10-13 | 2015-01-07 | 江南大学 | 基于三重信标修饰的金纳米粒子三聚体的表面增强拉曼散射效应检测水溶液中Hg2+和/或Ag+的方法 |
CN104931478A (zh) * | 2015-06-11 | 2015-09-23 | 江南大学 | 基于银纳米粒子三聚体的表面增强拉曼散射效应超灵敏检测甲胎蛋白的方法 |
-
2016
- 2016-07-29 CN CN201610613233.8A patent/CN106290898B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005098441A2 (en) * | 2004-03-30 | 2005-10-20 | Intel Corporation | Method to detect molecular binding by surface-enhanced raman spectroscopy |
CN101484002A (zh) * | 2006-05-03 | 2009-07-15 | 加利福尼亚大学董事会 | 使用单个纳米新月形表面增强拉曼散射探针检测蛋白酶和蛋白酶活性 |
US20130330839A1 (en) * | 2010-11-24 | 2013-12-12 | Snu R&Db Foundation | Single nanoparticle having a nanogap between a core material and a shell material, and preparation method thereof |
CN104263837A (zh) * | 2014-10-13 | 2015-01-07 | 江南大学 | 基于三重信标修饰的金纳米粒子三聚体的表面增强拉曼散射效应检测水溶液中Hg2+和/或Ag+的方法 |
CN104931478A (zh) * | 2015-06-11 | 2015-09-23 | 江南大学 | 基于银纳米粒子三聚体的表面增强拉曼散射效应超灵敏检测甲胎蛋白的方法 |
Non-Patent Citations (3)
Title |
---|
LIGUANG XU等: "SERS Encoded Silver Pyramids for Attomolar Detection of multiplex disease biomarkers", 《ADVANCED MATERIALS》 * |
SI LI等: "Dual-Mode Ultrasensitive Quantification of MicroRNA in Living Cells by Chiroplasmonic Nanopyramids Self-Assembled from Gold and Upconversion Nanoparticle", 《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》 * |
XIAOLING WU等: "SERS-active silver nanoparticle trimers for sub-attomolar detection of alpha fetoprotein", 《THE ROYAL SOCIETY OF CHEMISTRY》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109097356A (zh) * | 2018-09-07 | 2018-12-28 | 江南大学 | 一种基于金壳-上转换纳米颗粒手性五聚组装体的制备方法 |
CN109097356B (zh) * | 2018-09-07 | 2021-06-22 | 江南大学 | 一种基于金壳-上转换纳米颗粒手性五聚组装体的制备方法 |
CN109283333A (zh) * | 2018-09-21 | 2019-01-29 | 江南大学 | 一种基于金壳-上转换手性二聚体对大肠杆菌耐药性定量分析的方法 |
CN109283333B (zh) * | 2018-09-21 | 2021-11-12 | 江南大学 | 一种基于金壳-上转换手性二聚体对大肠杆菌耐药性定量分析的方法 |
CN111624186A (zh) * | 2020-06-24 | 2020-09-04 | 江南大学 | 一种基于荧光和拉曼双信号增强的肠毒素光谱分析方法 |
CN111624186B (zh) * | 2020-06-24 | 2021-03-16 | 江南大学 | 一种基于荧光和拉曼双信号增强的肠毒素光谱分析方法 |
CN111999504A (zh) * | 2020-08-10 | 2020-11-27 | 江南大学 | 一种粘蛋白1及其唾液酸糖基的双重荧光成像方法及应用 |
CN111999504B (zh) * | 2020-08-10 | 2021-09-28 | 江南大学 | 一种粘蛋白1及其唾液酸糖基的双重荧光成像方法及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN106290898B (zh) | 2017-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ye et al. | Advances in nanotechnology for cancer biomarkers | |
Koo et al. | Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management | |
Ning et al. | Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients | |
Díaz-Fernández et al. | Electrochemical aptasensors for cancer diagnosis in biological fluids–a review | |
Zhao et al. | Aptamer-based fluorescent sensors for the detection of cancer biomarkers | |
US10712343B2 (en) | Molecular analysis of tumor samples | |
De La Franier et al. | Early stage detection and screening of ovarian cancer: A research opportunity and significant challenge for biosensor technology | |
Young et al. | Validation of biomarkers for early detection of pancreatic cancer: summary of the alliance of pancreatic cancer consortia for biomarkers for early detection workshop | |
Urquidi et al. | CCL18 in a multiplex urine-based assay for the detection of bladder cancer | |
CN106290898A (zh) | 一种金‑上转换纳米粒子三聚体的制备方法及其应用 | |
Koster et al. | Surface enhanced Raman scattering of extracellular vesicles for cancer diagnostics despite isolation dependent lipoprotein contamination | |
Han et al. | Glypican-3-targeted precision diagnosis of hepatocellular carcinoma on clinical sections with a supramolecular 2D imaging probe | |
Wu et al. | Advances in biomarkers and techniques for pancreatic cancer diagnosis | |
Shi et al. | A hybridization chain reaction based assay for fluorometric determination of exosomes using magnetic nanoparticles and both aptamers and antibody as recognition elements | |
WO2018157831A1 (zh) | 一种肺癌监测试剂盒及其使用方法 | |
Su et al. | Peptide and protein modified metal clusters for cancer diagnostics | |
CN110914687A (zh) | 血浆微量样品中肿瘤源性细胞外囊泡的纳米等离激元定量 | |
Liu et al. | Rapid visualizing and pathological grading of bladder tumor tissues by simple nanodiagnostics | |
CN109682972A (zh) | 一种检测乳腺癌肿瘤循环细胞的sers试剂 | |
Mao et al. | One-pot and one-step colorimetric detection of aminopeptidase N activity based on gold nanoparticles-based supramolecular structure | |
Hu et al. | Ultrasensitive dynamic light scattering immunosensing platform for NT-proBNP detection using boronate affinity amplification | |
Yin et al. | Simultaneous determination of two phosphorylated p53 proteins in SCC-7 cells by an ICP-MS immunoassay using apoferritin-templated europium (III) and lutetium (III) phosphate nanoparticles as labels | |
Chen et al. | AuNPs and 2D functional nanomaterial-assisted SPR development for the cancer detection: a critical review | |
Morris | Fluorescent biosensors for cancer cell imaging and diagnostics | |
EP3410118A1 (en) | Prostate carcinoma determination method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder |
Address after: 214002 Liangxi Food Science and Technology Park, 7 Floors South Building, 898 Tongsha Road, Liangxi District, Wuxi City, Jiangsu Province Patentee after: Jiangnan University Address before: Food College of Jiangnan University No. 1800 214122 Jiangsu city of Wuxi province Wuxi City Binhu Lihu Avenue Patentee before: Jiangnan University |
|
CP02 | Change in the address of a patent holder |